Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial (Q38378516)
Jump to navigation
Jump to search
scientific article published on September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial |
scientific article published on September 2016 |
Statements
1 reference
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial (English)
1 reference
Sandra P D'Angelo
1 reference
Howard L Kaufman
1 reference
Jeffery Russell
1 reference
Omid Hamid
1 reference
Shailender Bhatia
1 reference
Patrick Terheyden
1 reference
Kent C Shih
1 reference
Céleste Lebbé
1 reference
Gerald P Linette
1 reference
Michele Milella
1 reference
Isaac Brownell
1 reference
Karl D Lewis
1 reference
Jochen H Lorch
1 reference
Kevin Chin
1 reference
Lisa Mahnke
1 reference
Anja von Heydebreck
1 reference
Jean-Marie Cuillerot
1 reference
Paul Nghiem
1 reference
1 reference
Identifiers
1 reference